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1. IxrnonucrroN
Article 251(2),third subparagraph, point (c) of the EC Treaty provides that the Commission is
to deliver an opinion on the amendments proposed by the European Parliament at second
reading. The Commission sets out its opinion below on the 29 amendments proposed by
Parliament.
2. BacrcnouNn
The Commission adopted it initial proposal on 5th April2000t.
The Economic and Social Committee gave its opinion on 20th September 20002.
The European Parliament approved the proposal with amendments in the first
reading on 3'o April 2001'.
- 
The Commission adopted its amended proposal on22"d November 200f .
- 
The Council adopted its Common Position on l4thFebruary 2OO2s.
- The Commission supported the corrunon position6.
- The European Parliament approved the proposal with amendments in the second
reading on 1lth June20027.
OJ C 3l 1 E, 31.10.2000, p. 134.
OJ C 367, 20.12.2000, p. l.
OJ C 21 8,24.1.2002, p. 104.
OJ C 5l 8,26.2.2002, p.385.
OJ C I l3E, 14.5.2N2,p. 109.
sEC(2002) 22s.
Not yet published in the OJ.
3. PunposnoFTHEPRoPosAL
The main objective of the initial proposal was to settle definitively the question of anirnal
testing in theiosmetic sector. The main elements of the initial proposal werc the introduct:ion
of a fermanent and definitive prohibition to perform tests on animals for finished cosmeric
products and a switch from a marketing ban of cosmetic products containing ingredients
testecl on animals to a ban to perform tests in the EU on animals for ingredients used in
cosmetic products to comply with wTo rules. The date of implementatiOn of this ban r,vas
foreseen thr"e yeu6 afteritre date of implementation of the proposed Directive; h-c'Heve-r it
could be postponed for no nrore than two years if there had been insufficient prcgress :lt
developing satisfactory methods to replace animal testing scientifically vali'dated.
xn its amended proposal, the commission incorporated many suggestions from the Er-lroprlan
parliament, which aim to improve health and consumer protection. The Comrnon Position
also included these suggestiotts.
4. OPNTON OF TIIE COUUISSTON ON THE AMENDMENTS BY TIIE EUNOPNIX
Plnr.rnunltr
4.1. Amendments acceptedby the Commission
o The Commission can accept in principle the frst part of amend!09$-1-which proposes the
inclusion of a reference to Directive 86/609/EEC relating to the protection of animals used
for experimental and other scientific purposes. This reference is already included in
recital3 of the Common Position.
o The Commission can accept the first part of amendment 5 which requests to "increase"
the efforts in the development and validation of alternative methods, as it is already
foreseen for the implementation of the Chemical policy. Therefore, recital 6 should read as
follows: "Better coordination of resources at Community level will contribute to
increasing the scientific knowledge indispensahle for the development of alternative
methods. It is essential, Jbr this purpose, that the Community continue and increaset its
efforts and take the measures necessary for the promotion of research and the developntent
of new methods, in particular within its Sixth Framev,ork Programme as set ou;r in
Decision No 2002/...../EC of the European Parliament and of the Counc:il" .
o The Commission can accept the seqond part ata!0endn0gn!-2Z which requests the addi'tion
of the following paragraph: "The Comrnission shall in particular ensure the developftrent,
validation and legal accepttance of alternative test methods which do not use live animals" "
r The Commission can accept in principle the secqnd part of anrqndment 28. It would accept
the principle of the listing of the recognised fragrance allergens in Ann*x III of
Directive 76fl68lEEC according to the suggested modalities (setting of threshold levels
suggesred by the SCCNFP). However, according to Directive 76l768lEEC, the proposed
modification of Annex III has to be implemented via a Commission tr)irective adapting to
technical progress, adopted under the comitology procedure.
4.2, Amendments rejected by the Commission
o The Commission cannot accept the second part of amendment I whicli requests xhe
Commission to present another proposal for amending Directive 86/609/EEC. It is contrary
to the right of initiative of the Commission. The Commission has already rnade a
declaration at the Internal Market Council of November 200i confirming "its intention
shortly to begin work on the revision of Directive 86/609/EEC".
The Commission cannot accept amendments 2. 4. 15 and 16 dealing witli the EU testing
ban for ingredients. These amendments reintroduce the concept of a cut-off clate fclr the
testing ban which is contrary to the approach adopted by the Council in its Corunon
Position supported by the Commission. They contradict the aim to ensure the key
objectives of consumer protection and public health, taking into account the expected
progress in developing satisfactory methods to replace animal testing scientifically
validated as offering an equivalent level of protection for the consumer. The proposed
system ofderogation restricted to existing ingredients is contrary to the progressive testing
ban adopted in the Common Position supported by the Commission.
The Commission cannot accept amendment 3 which deletes the prioritisation of alternative
methods (according to the 3Rs principle: replacement, reduction, refinement) introduced in
the Common Position supported by the Commission.
The Commission cannot accept amendment 30 which requests the setting up of a fixed
timetable for the tests within 5 years. The current scientific prospects cannot ensure the
validation of the methods undbr development, bearing in mind that one in-vitro method has
alreadv failed at validation.
The Commission cannot accept the second part of amendment 5 which would restrict the
scope of research to non-animal alternative methods without taking into account the 3Rs
principle.
The Commission cannot accept amendment 6, which requests the Commission to present
another proposal, being contrary to the right of initiative of the Commission.
The Commission cannot accept amendments 7. 13 and 31 reintroducing the rnarketing ban
as and when alternatives are available, with a definitive date after which no products can
be marketed if tested on animals, whether or not there are validated alternatives. It is
contrary to the approach adopted by the Council in its Common Position, i.e. the
introduction of a progressive marketing ban subject to the previous acceptance of
alternative methods at OECD level, in order to reduce the risk of a challenge under WTO.
The suggested marketing ban is in contradiction with the purpose of the Commission to
avoid a unilateral action by the Community. It is not in confbrmity with WTO rules and is
likely to be challenged. The Commission will pursue its effort to promote rapid
international acceptance of alternative methods at OCDE level. Having noted the concerns
of public opinion, it will stimulate discussions on trade and animal welfare in a multilateral
forum. A unilateral Community ban on marketing would be contrary to the policy of a
multilateral approach to animai welfare trade issues. The Community has taken a position
that discussions on trade and animal welfare (and other PPMs issues) should be conducted
in a multilaterai forum. Such a unilateral action would undermine this multilateral
approach. The Commission underlines its commitment to the use of international standards
as a basis for measures which have a trade impact. The Community would be in
contradiction with its internationai commitments to accept the results of tests carried out on
animals in thfud countries because of the mutual acceptance of data agreement.
Furthermore, considering the development of alternatives, the time scale suggested for its
implementation is not realistic. It should take into account the development and
international acceptance of alternative methods to ensure that consumer safety is not
endangered. Only a co-ordinated approach at international level wiii impi'i-rr'g flfi.'::i
welfare, and on a wider sc:ale.
The Commission cannot accept the additional requirement of compulsory labelling 'lested
on animals" required by 4mendments 7 and 22. Such amendment is not proportionate and
may raise concerns, u*tog others under the TBT agreement, since rnost imported products
would bear this mention'
The Commission cannot accept amendments 8 and 23 dealing rvith the use *f clain::
relating to animal testing. These are contrary to the intention of the Comrnission to avoid
the use of such claims that mislead consumers by giving them the impression tltat flcrric of
the ingredients contained in the products have been tested on animals - whilst such tesri
have iecessarily been performed on almost every ingredient at least once by sttmeone. Th*
aim of the Commission .is to avoid misleading claims and give contplete informaticfi tc;
consumers. The details r;hould be dealt with in the production of guidelines whero ali
interested parties will be irnvolved.
The Commission cannot accept amendment 9 aiming to avoid use of'fragrunces in sorne
categories except when they ftrlfil specific purposes. The suggested han rvould Lte contrary
96 tfe principlei of neces,siiy.and pioportionality. Safety requirements for some categaiies
oi'projucts such as prodgcts for children and intimate hygiene products have already been
reinforced tiuough a new provision.
, The Conrmission cannot accept amendments 10. 11*14 and 18 leading to a general ban
which is contrary to the principie of risk assessment set up in DirectiveT6ll6SlEH{l' The
Common position has already introducecl specific provisions regarding substances u'hicir
are carcinogenic, mutagr:nic and toxic. for reproduction (CMR), taking into accottnt the
latest scieniific opinion, in line with the principle of risk assessment. The Commir;sion
shares the Parliament's objective to prevent risks to consumer heaittr due fct
CMR-substances in cosmetic products. Directive 7617681EEC already regulates the use of
CMR-substances in cosuretic products in a sectorial rnanner. Restrictions of use or bans are
imposed by the oveniding sif"ty and product information requirements and by specific
rejuhtion of such substances in the annexes of this Directive. Even if the Commission
u.i"p6 the principle that ingredients which are siassified as CMR-substances, categoies I
and 2 should in general not be used in cosmeiics, it wishes to ensure that this regulator.v
approach is consistent with ihe cosmetics legislation and the approach of the White Papei
on Chemical Policy. Irurthermore, this issue has already been considered b1' t"he
Commission on a horizo:rrtal basis in the proposed White Paper on the new chemical poiicS'
which pians to ban the use of substances classified in categories 1 or 2 as cuciucgeni;,
mutagenic or toxic *:r reprr:ductiorl under Annex 1 of Directive67l548lEEc, e.Kcept
following a procedure o,f authorisation providing that companies show their safe use f,or
certain purposes. This approach will be incorporated into the future proposals for a lrelv
Community legislation on chemicals. The provisions concerning CMR-substances ln
cosrnetics should be consistent with that approach.
o The Commission cannot accept amendment 12 dealing with ingredients potentiali5"
allergenic. Recital 1 1 of the Comrnon Position already specifies the measures requested f*-:r
fragiance allergens, i.e. information to consumer through labelling, as suggested b,r' tlrc
relevant Scientific Comrnittee.
The Commission cannot accept amendment 17 dealing with the definition of finishecl
products. This definition has aheady been reconsidered in the Common Position with the
aim of achieving a consistent and coherent legislation.
The Commission cannot accept amendments 19 and 26 aimed at publishing all data
concerning each cosmetic product in the Inventory. Such information is part of the product
information required for the effective in-market control system estatrlished by the
6'h amendment to ensure free movement of goods while ensuring consumer safety. This is
not the purpose of the Inventory of cosmetic ingredients published by the Commission.
Furthermore, such a proposal would raise concerns in terms of industry property rights and
trade secrecy, and could lead to unfair competition, while not improving consumer
information.
The Commission cannot accept amendments 20 and 29 dealing with the durability of
cosmetic products. The provisions on the minimum durability date have already been
reconsidered in order to provide the consumer with helpful information in a coherent and
proportionate manner. The suggestion for a symbol is been considered in the whole
reflection on this issue; however, the open-jar is not considered as the more appropriate.
The Commission cannot accept amendment 21 and the first part of amendment 28, which
aim to achieve a full ingreilient listing, including perfume composition. Such a fulI
labelling of all fragrance ingredients would neither be feasible nor helpful to sensitised
consumers or dermatologists and would be disproportionate to the anticipated risks. The
SCCNFP has expressed the opinion that fragrance ingredients have to be considered as an
important cause of contact allergy and have identified 26 fragrance ingredients, which
correspond to the most frequently recognised allergens. Information should be provided to
consumers about the known presence in cosmetic products of fragrance ingredients with
well-recognised potential to cause contact allergy. The Common Position has already
introduced the legal basis to allow the labelling of such ingredients by arnending the
current Article6.1.g). It cannot accept the deletion of this modification suggested in
amendment 21 which would withdraw the legal basis for requesting the labelling of
fragrances with potential allergenic effects as requested in the second part of
amendrnent23. Furthermore, according to ArticleS(2) of Directive76|768/EEC, the
modification of Annex III proposed in amendment 28 has to be implemented via a
Commission Directive adapting to technical progress, adopted under the comitology
procedure.
The Commission cannot accept amendment 24 dealing with the product information, the
current legisiation already specifies that the information is accessible for control authorities
for control purposes.
The Commission cannot accept amendment 25, suggesting additional data on animal tests
performed should be included in the product information required for each cosmetic
product put on the market. This additional requirement obliging the manufacturer to check
if any of the ingredients used have been tested once on animals somewhere in the world is
impossibie to fulfil, and could raise concerns under the TBT agreement (Article 5.2.3).
The Commission cannot accept the first part of amendment 27 which requests an annual
report. The requirement for a report every 3 years aims to provide a better overview of the
progress made and align it to the Report requested in the framework of
Directive 86/609|EEC, taking into account available resources.
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5. Cowcr,usron
pursuant to Article ZS}1Z) of the EC Treaty, the Commission arnends its proposal as set out
above.
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